Spectral Medical (TSX: EDT) posts C$2.44m revenue as PMA submission slips to May 2026 and derivative liabilities widen the reported loss
Oxford Biomedica (LSE: OXB) delivers first EBITDA profit as revenue surges 33% and BMS CAR-T deal signals commercial maturity
Ola Electric’s #EndICEAge campaign slashes entry price to Rs 49,999 to reclaim lost ground in India’s electric two-wheeler market
Read More 3 minute read Pharma Industry News Marksans Pharma smashes records: 18% revenue surge and massive profit boost in Q1 FY25 Marksans Pharma Ltd. (NSE: MARKSANS; BSE Code: 524404) has unveiled its financial results for the quarter ending June… byPallavi MadhirajuAugust 13, 2024